Now Approved For Cats
NOCITA is now FDA-approved for use in cats as a peripheral nerve block to provide regional post-operative analgesia following onychectomy. Please see the full Prescribing Information for more detail.
(bupivacaine liposome injectable suspension)
Recovery care begins with NOCITA.
Now you can be sure dogs and cats are getting the post-surgical pain relief they need even after they leave your clinic. NOCITA is a long-acting local anesthetic that gives you the control of extended-release delivery of bupivacaine, providing up to 72 hours of post-operative pain relief with just one dose administered during surgery.
Controlling post-surgical pain
Post-surgical pain can typically be well controlled in hospitalized patients using a multimodal analgesic regimen involving an appropriate combination of opioids, COX-inhibiting NSAIDs, and long-acting NOCITA. However, most veterinary patients that undergo surgery are discharged from the veterinary hospital within 12-24 hours. Analgesics must be prescribed and/or delivered that provide continued pain relief in the home environment.
Limitations of local anesthetics (LAs)
One of the most effective means of preventing the transduction and transmission of pain is through the use of LAs. While their post-operative use is supported by AAHA/AAFP and WSAVA Pain Guidelines, there are limitations which function as barriers to their use. These include the technical difficulty associated with some nerve and epidural blocks, potential complications of the indwelling soaker catheter, and the short duration of action (<8 hours) of the available formulations.
To learn more about how NOCITA will help raise the standard of care for post-operative pain management in dogs, watch this video
Experience the Difference
“We began using Nocita on canine patients undergoing cranial cruciate ligament stabilization surgeries and have been very pleased with the results. The product is intuitive to use and we have observed nothing but positive effects for our patients post-operatively. Specifically, these patients appear to bear more significant weight immediately post-op than usually expected, require very little rescue analgesia, and are willing to eat early in the recovery period which has allowed easy transition to oral medications. Nocita has quickly become standard protocol for analgesia on our canine cruciate ligament stabilization procedures.”Veterinary Surgeon
DOG INDICATION: For single-dose infiltration into the surgical site to provide local post-operative analgesia for cranial cruciate ligament surgery in dogs.
IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for local infiltration injection in dogs only. Do not use in dogs younger than 5 months of age, that are pregnant, lactating or intended for breeding. Do not administer by intravenous or intra‐arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.
CAT INDICATION: For use as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats.
IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use as a peripheral nerve block in cats only. Do not use in cats younger than 5 months of age, that are pregnant, lactating, or intended for breeding. Do not administer by intravenous or intra‐arterial injection. Adverse reactions in cats may include elevated body temperature, infection or chewing/licking at the surgical site. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.
Other therapeutics from Aratana
Finally, appetite stimulation is in your control.
ENTYCE® (capromorelin oral solution) is the ONLY FDA-approved veterinary therapeutic designed to safely and effectively stimulate appetite in dogs. Administered orally once a day, ENTYCE is appropriate for treating inappetence caused by chronic and acute conditions.
IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.